Hepatic steatosis associated with exposure to elvitegravir and raltegravir. Kirkegaard-Klitbo DM, Thomsen MT, Gelpi M, Bendtsen F, et al. Clin Infect Dis 2021 Jan 25. pii: 6119572. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Kirkegaard-Klitbo DM, Thomsen MT, Gelpi M, Bendtsen F, et al. Hepatic steatosis associated with exposure to elvitegravir and raltegravir. Clin Infect Dis 2021 Jan 25. pii: 6119572. doi: 10.1093.
PMID: 33493297